Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
4(29%)
Results Posted
29%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
2
14%
Ph not_applicable
11
79%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
2(15.4%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
Recruiting4
Suspended2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
87.5%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (15.4%)
N/A11 (84.6%)

Trials by Status

suspended214%
terminated17%
completed750%
recruiting429%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DEVICE
Total Trials
14